๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phase II trial of amonafide in advanced pancreas cancer

โœ Scribed by Cynthia Gail Leichman; Cathy Tangen; John S. Macdonald; Thomas Leimert; Thomas R. Fleming

Publisher
Springer US
Year
1993
Tongue
English
Weight
234 KB
Volume
11
Category
Article
ISSN
0167-6997

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Phase II study of amonafide in advanced
Phase II study of amonafide in advanced pancreatic adenocarcinoma
โœ Kaye Linke; Richard Pazdur; James L. Abbruzzese; Jaffer A. Ajani; Rodger Winn; J ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› Springer US ๐ŸŒ English โš– 262 KB

To determine the efficacy of amonafide in patients with advanced, measurable pancreatic adenocarcinoma, 15 patients previously untreated with chemotherapy were entered on a phase II trial. The starting dose was 400 mg/m 2 administered daily over 1 hr for 5 consecutive days repeated every 3 weeks. Be

Phase II trial of menogaril in advanced
Phase II trial of menogaril in advanced colorectal cancer
โœ Eduard E. Holdener; Wim W. Bokkel Huinink; Genevieve Decoster; Christian Ludwig; ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› Springer US ๐ŸŒ English โš– 262 KB

Menogaril, a new semisynthetic anthracycline antibiotic, was administered to 35 patients with advanced colorectal cancer. The drug was infused over 2 hr at a dose of 160 mg/sqm or 200 mg/sqm repeated every 4 weeks. Twenty-seven patients were evaluable for response and no objective responses were ach